Home › Synergy Pharmaceuticals Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation
 

Keywords :   


Synergy Pharmaceuticals Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation

2016-02-03 01:28:06| drugdiscoveryonline News Articles

Synergy Pharmaceuticals Inc. recently announced the company has filed with the U.S. Food and Drug Administration (FDA) its first new drug application (NDA) for plecanatide in chronic idiopathic constipation (CIC)

Tags: application files drug chronic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Teenagers could help fill train driver shortage
16.05Peak-time ScotRail fares scrapped for further three months
16.05Japanese brand to launch TVs 'Powered by TiVo'
16.05Disney and WBD announce Disney+, Hulu, Max bundle
16.05VIZIO reports Q1 2024 financial results
16.05Pixalate releases Q1 2024 CTV ad supply chain report
16.05'Time running out' plea over shipyard's future
16.05Eastern North Pacific Tropical Weather Outlook
More »